In agreement with these in vitro results, immunohistochemical assays revealed significantly reduced HES6 protein levels in cancers from men who had undergone long-term androgen deprivation therapy (ADT) compared to ADT-naïve cancers (Fig.5E and F). The gene discussed is HES6; the disease is cancer.